Insider Transactions in Q1 2023 at Icosavax, Inc. (ICVX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2023
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
5,000
-3.19%
|
$35,000
$7.75 P/Share
|
|
Feb 15
2023
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
10,677
+4.01%
|
$10,677
$1.04 P/Share
|
|
Feb 14
2023
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,349
-1.14%
|
$33,490
$10.17 P/Share
|
|
Feb 13
2023
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
7,506
-2.97%
|
$75,060
$10.69 P/Share
|
|
Feb 13
2023
|
Elizabeth Bekiroglu General Counsel & Corp. Sec. |
SELL
Open market or private sale
|
Direct |
5,922
-5.44%
|
$59,220
$10.69 P/Share
|
|
Feb 13
2023
|
Thomas Joseph Russo |
SELL
Open market or private sale
|
Direct |
1,902
-3.76%
|
$19,020
$10.69 P/Share
|
|
Feb 13
2023
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,522
-0.52%
|
$15,220
$10.69 P/Share
|
|
Feb 13
2023
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
1,660
-1.05%
|
$16,600
$10.69 P/Share
|
|
Feb 13
2023
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
1,794
-0.74%
|
$17,940
$10.69 P/Share
|
|
Jan 30
2023
|
Cassia Cearley |
BUY
Exercise of conversion of derivative security
|
Direct |
25,102
+13.8%
|
$0
$0.84 P/Share
|
|
Jan 25
2023
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
13,073
+2.52%
|
$0
$0.94 P/Share
|
|
Jan 04
2023
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
106,373
-32.2%
|
$1,595,595
$15.7 P/Share
|
|
Jan 04
2023
|
Niranjan Kanesa Thasan |
BUY
Exercise of conversion of derivative security
|
Direct |
106,373
+7.53%
|
$531,865
$5.7 P/Share
|